PCM
NVO

Pinnbrook Capital Management’s Novo Nordisk NVO Stock Holding History

Pinnbrook Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-39,141
Closed -$1.99M – 98
2025
Q4 		$1.99M Buy
+39,141
New +$2M 0.28% 86
2024
Q3 		– Sell
-5,710
Closed -$815K – 92
2024
Q2 		$815K Buy
+5,710
New +$757K 0.17% 55
2024
Q1 		– Sell
-40,468
Closed -$4.19M – 130
2023
Q4 		$4.19M Buy
+40,468
New +$4M 0.47% 48

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Pinnbrook Capital Management's NVO Position: Q1 2026 in Review

Pinnbrook Capital Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 39,141 shares — an estimated $1.99M sold.

Pinnbrook Capital Management first reported a position in NVO in Q4 2023 and held it in 3 quarters. The position peaked at $4.19M in Q4 2023. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Pinnbrook Capital Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Pinnbrook Capital Management sold 39,141 Novo Nordisk shares in Q1 2026, an estimated $1.99M.
  • Pinnbrook Capital Management first reported a position in Novo Nordisk in Q4 2023 and held it in 3 quarters.
  • Pinnbrook Capital Management's Novo Nordisk position peaked at $4.19M in Q4 2023.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Pinnbrook Capital Management's 13F filing for Q1 2026, filed 14 May 2026.